Share-Based Compensation

Employee Share-Based Compensation Plans - On May 29, 2008, the Company's shareholders approved the 2008 Omnibus Employee Incentive Plan (the "2008 Plan") providing for the grant of stock options, stock appreciation rights, non-vested stock, and performance shares. The 2008 Plan provides for the issuance of an aggregate of 333,333 shares. There were no options for the purchase of shares granted under the 2008 Plan for the year ended December 31, 2017. During the year ended December 31, 2016, the Company granted 187,832 options for the purchase of shares under the 2008 Plan. As of December 31, 2017, 114,141 shares remain available for grant under the 2008 Plan.

On May 24, 2011, the Company's shareholders approved the 2011 Omnibus Employee Incentive Plan (as subsequently amended and restated (the "2011 Plan"), providing for the grant of stock options and non-vested stock awards. The 2011 Plan provides for the issuance of an aggregate of 3,650,000 shares, increased from 633,333 shares during 2017. During the years ended December 31, 2017 and 2016, the Company granted a total of 435,800 and 166,665 stock awards, respectively, to non-employee members of the Board of Directors that immediately vested. During the years ended December 31, 2017 and 2016, options for the purchase of 2,550,000 and 7,500 shares, respectively, were granted under the 2011 Plan. As of December 31, 2017, 567,893 shares remain available for grant under the 2011 Plan.

Options under the 2008 and 2011 Plans are granted at fair value on the date of grant, are exercisable in accordance with various vesting schedules specified in the individual grant agreements, and have contractual lives of 10 years from the date of grant.

The fair value of each stock option granted during the year was estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:



	2017		2016
Expected life (years)	4.0		4.8
Expected volatility	91	%	83	%
Risk-free interest rate	1.7	%	1.4	%
Weighted average fair value of options granted during the year	$0.40		$1.21

The expected life of options granted is derived from our historical experience and represents the period of time that options granted are expected to be outstanding. Expected volatility is based on our historical volatility. The risk-free interest rate for periods within the contractual life of the options is based on the U.S. Treasury yield curve in effect at the time of the grant.

The following table summarizes stock option activity for the year ended December 31, 2017:



				Weighted
			Weighted Average	Average Remaining	Aggregate Intrinsic
	Number of Shares		Exercise Price Per Share	Contractual Life (years)	Value (in thousands)
Outstanding at December 31, 2015	286,568		$6.46
Granted	195,332		$1.86
Forfeited and Expired	(77,914	)	$4.46
Outstanding at December 31, 2016	403,986		$4.62	8.1	$0
Granted	2,550,000		$0.65
Forfeited and Expired	(376,126	)	$1.35
Outstanding at December 31, 2017	2,577,860		$1.17	8.7	$0
Exercisable at December 31, 2017	217,066		$6.04	6.4	$0

There were no options exercised for the years ended December 31, 2017 and 2016, under either the 2008 or 2011 plans.

Options for the purchase of 56,682 and 86,736 shares of common stock, respectively, vested during the years ended December 31, 2017 and 2016, and the aggregate fair value at grant date of these options was $0.1 million and $0.3 million, respectively. As of December 31, 2017, there was approximately $0.4 million of unrecognized compensation cost related to stock options which is expected to be recognized over a weighted average period of 3.2 years.

The Company recorded $0.8 million and $0.6 million, of share-based compensation expense in selling, general and administrative expenses for each of the years ended December 31, 2017 and 2016, respectively, related to stock options, non-vested stock, and restricted stock awards.